Literature DB >> 15618788

Electronic nose prediction of a clinical pneumonia score: biosensors and microbes.

C William Hanson1, Erica R Thaler.   

Abstract

BACKGROUND: The authors performed a prospective study to determine whether breath test analysis using an electronic nose correlates with a clinical pneumonia score.
METHODS: Exhaled gas was sampled from the expiratory limb of the ventilator in mechanically ventilated surgical intensive care patients and assayed with the electronic nose. Components of a clinical pneumonia score were recorded concurrently.
RESULTS: The score predicted by the electronic nose showed good correlation with the actual pneumonia score (r = 0.81). Bland Altman analysis showed a mean bias of 0.0 (limits +/- 2.6).
CONCLUSIONS: The electronic nose is a new biosensor technology that correlates with a clinical pneumonia score.

Entities:  

Mesh:

Year:  2005        PMID: 15618788     DOI: 10.1097/00000542-200501000-00013

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  26 in total

Review 1.  Advances in electronic-nose technologies developed for biomedical applications.

Authors:  Alphus D Wilson; Manuela Baietto
Journal:  Sensors (Basel)       Date:  2011-01-19       Impact factor: 3.576

Review 2.  Electronic Nose Technology in Respiratory Diseases.

Authors:  Silvano Dragonieri; Giorgio Pennazza; Pierluigi Carratu; Onofrio Resta
Journal:  Lung       Date:  2017-02-25       Impact factor: 2.584

3.  Structural characterization of chlorophyll-a by high resolution tandem mass spectrometry.

Authors:  Juan Wei; Huilin Li; Mark P Barrow; Peter B O'Connor
Journal:  J Am Soc Mass Spectrom       Date:  2013-03-16       Impact factor: 3.109

4.  Innovations that could improve early recognition of ventilator-associated pneumonia.

Authors:  Lieuwe D J Bos; Ignacio Martin-Loeches; Antonio Artigas
Journal:  Intensive Care Med       Date:  2014-06-05       Impact factor: 17.440

5.  Comparison of volatile organic compound profiles in exhaled breath versus plasma headspace in different diseases.

Authors:  David Grove; Galen Miller-Atkins; Celia Melillo; Florian Rieder; Satya Kurada; Daniel M Rotroff; Adriano R Tonelli; Raed A Dweik
Journal:  J Breath Res       Date:  2020-05-27       Impact factor: 3.262

Review 6.  Clinical application of volatile organic compound analysis for detecting infectious diseases.

Authors:  Shneh Sethi; Ranjan Nanda; Trinad Chakraborty
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

Review 7.  Microbial volatile compounds in health and disease conditions.

Authors:  Robin Michael Statham Thorn; John Greenman
Journal:  J Breath Res       Date:  2012-05-04       Impact factor: 3.262

Review 8.  Antimicrobial resistance in the next 30 years, humankind, bugs and drugs: a visionary approach.

Authors:  Matteo Bassetti; Garyphallia Poulakou; Etienne Ruppe; Emilio Bouza; Sebastian J Van Hal; Adrian Brink
Journal:  Intensive Care Med       Date:  2017-07-21       Impact factor: 17.440

9.  Molecular analysis of volatile metabolites released specifically by Staphylococcus aureus and Pseudomonas aeruginosa.

Authors:  Wojciech Filipiak; Andreas Sponring; Maria Magdalena Baur; Anna Filipiak; Clemens Ager; Helmut Wiesenhofer; Markus Nagl; Jakob Troppmair; Anton Amann
Journal:  BMC Microbiol       Date:  2012-06-20       Impact factor: 3.605

Review 10.  Clinical use of exhaled volatile organic compounds in pulmonary diseases: a systematic review.

Authors:  Kim D G van de Kant; Linda J T M van der Sande; Quirijn Jöbsis; Onno C P van Schayck; Edward Dompeling
Journal:  Respir Res       Date:  2012-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.